IRIS
ANGARANO, Gioacchino
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 28.673
AS - Asia 9.603
EU - Europa 8.970
SA - Sud America 2.911
Continente sconosciuto - Info sul continente non disponibili 698
AF - Africa 444
OC - Oceania 13
AN - Antartide 2
Totale 51.314
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.119
SG - Singapore 3.907
IT - Italia 2.770
BR - Brasile 2.319
CN - Cina 2.145
DE - Germania 1.525
HK - Hong Kong 1.509
SE - Svezia 872
UA - Ucraina 836
RU - Federazione Russa 771
FI - Finlandia 654
VN - Vietnam 564
FR - Francia 557
GB - Regno Unito 491
IN - India 321
CA - Canada 258
BD - Bangladesh 257
AR - Argentina 193
IQ - Iraq 125
CI - Costa d'Avorio 120
ID - Indonesia 111
ZA - Sudafrica 97
EC - Ecuador 96
MX - Messico 94
CO - Colombia 82
TR - Turchia 81
PK - Pakistan 74
VE - Venezuela 72
BE - Belgio 69
SA - Arabia Saudita 68
IE - Irlanda 59
JP - Giappone 59
PL - Polonia 55
ES - Italia 52
MA - Marocco 51
NL - Olanda 48
UZ - Uzbekistan 47
PY - Paraguay 43
PH - Filippine 39
CR - Costa Rica 38
TN - Tunisia 37
KE - Kenya 36
PE - Perù 36
CL - Cile 35
AT - Austria 32
JO - Giordania 32
IL - Israele 30
MK - Macedonia 29
IR - Iran 26
MY - Malesia 25
NI - Nicaragua 24
EG - Egitto 22
SV - El Salvador 22
AE - Emirati Arabi Uniti 21
JM - Giamaica 21
CW - ???statistics.table.value.countryCode.CW??? 20
LT - Lituania 20
HN - Honduras 19
NP - Nepal 19
TT - Trinidad e Tobago 19
AZ - Azerbaigian 18
ET - Etiopia 17
UY - Uruguay 17
KZ - Kazakistan 15
LB - Libano 15
BO - Bolivia 14
BG - Bulgaria 13
OM - Oman 13
PS - Palestinian Territory 13
RO - Romania 13
RS - Serbia 13
TH - Thailandia 13
GT - Guatemala 12
HR - Croazia 12
AU - Australia 11
CZ - Repubblica Ceca 11
GE - Georgia 11
GP - Guadalupe 11
GR - Grecia 11
DZ - Algeria 10
EU - Europa 10
AL - Albania 9
BY - Bielorussia 9
KW - Kuwait 9
NG - Nigeria 9
PR - Porto Rico 9
CH - Svizzera 8
SC - Seychelles 8
BH - Bahrain 7
DO - Repubblica Dominicana 7
LY - Libia 7
HU - Ungheria 6
PT - Portogallo 6
SN - Senegal 6
AO - Angola 5
PA - Panama 5
QA - Qatar 5
XK - ???statistics.table.value.countryCode.XK??? 5
BB - Barbados 4
SY - Repubblica araba siriana 4
Totale 50.574
Salva come PNG Salva come JPEG
Città #
Ashburn 3.073
Fairfield 2.715
Singapore 2.007
Woodbridge 1.992
Jacksonville 1.865
San Jose 1.799
Chandler 1.704
Houston 1.509
Hong Kong 1.490
Seattle 1.126
Milan 1.076
Wilmington 1.008
Cambridge 910
Ann Arbor 840
Council Bluffs 635
Nyköping 577
Dallas 508
Beijing 497
Lawrence 465
Roxbury 464
Nanjing 448
New York 426
Lauterbourg 412
Rome 381
Los Angeles 317
Boardman 296
Des Moines 295
São Paulo 271
Princeton 231
Santa Clara 214
Helsinki 202
Ho Chi Minh City 175
Columbus 157
Bari 138
Buffalo 136
Shenyang 128
Abidjan 120
Hanoi 120
Hebei 120
Inglewood 119
San Diego 117
Munich 113
Dearborn 111
Nanchang 110
Brooklyn 105
Figino 96
London 79
Toronto 79
Turin 78
Chicago 75
Rio de Janeiro 74
Jiaxing 73
Tianjin 69
Dublin 58
Tokyo 56
Naples 55
Baghdad 53
Brussels 53
Falkenstein 52
Belo Horizonte 46
Dong Ket 46
Jakarta 46
Moscow 46
Phoenix 46
Curitiba 45
Guangzhou 45
Pune 45
Atlanta 44
Brasília 43
Frankfurt am Main 43
Warsaw 43
Montreal 42
San Francisco 42
Changsha 38
Johannesburg 38
Tashkent 38
Orem 37
Paris 36
Denver 33
Guayaquil 32
Mexico City 32
Chennai 31
Taranto 31
Washington 31
Nairobi 30
New Delhi 30
North Bergen 30
Campinas 29
Hefei 29
Lima 29
Salvador 29
Porto Alegre 28
Stockholm 28
Amman 27
Dhaka 27
Mumbai 27
Quito 27
Bologna 26
Nuremberg 26
San José 26
Totale 33.919
Salva come PNG Salva come JPEG
Nome #
Anemia as a risk factor for disease progression in patients admitted for COVID-19: data from a large, multicenter cohort study 439
Influence of HLA-B18 on liver fibrosis progression in a cohort of HIV/HCV coinfected individuals 399
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 377
Sphingomonas paucimobilis outbreak in a dialysis room: Case report and literature review of an emerging healthcare associated infection 284
Economic evaluation of HIV treatments: The I.CO.N.A. cohort study 253
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 234
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 232
Access to health services for undocumented immigrants in Apulia. 221
Variability OF HIV-1 V2 env domain for integrin binding: Clinical correlates 219
Cerebrospinal fluid compartmentalization of HIV-1 and correlation with plasma viral load and blood–brain barrier damage 215
HCV mono-infected and HIV/HCV co-infected individuals treated with direct-acting antivirals: to what extent do they differ? 209
HIV-RNA decay in paired blood and semen samples of subjects receiving their first dolutegravir-based ART regimen 206
Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART 200
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients. 197
An outbreak of HIV-1 BC recombinants in Southern Italy 195
Knowledge, attitudes, and practices about HIV and other sexually transmitted infections among High School students in Southern Italy: A cross-sectional survey 188
Access to HAART in HIV-Infected Immigrants: A Retrospective Multicenter Italian Study 187
Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: A multicenter retrospective cohort study from 2007 to 2015 187
An intricate case of multidrug resistant Plasmodium falciparum isolate imported from Cambodia 184
Acute hepatitis C: A 24-week course of pegylated interferon alpha-2b versus a 12-week course of pegylated interferon alpha-2b alone or with ribavirin. 182
Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients 182
HIV-1 coreceptor tropism: A syllogistic connection with the veterans aging cohort study index and the CD4/CD8 ratio 178
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 177
" INFEZIONI DA CLAMYDIA PNEUMONIAE IN PAZIENTI CON A.I.D.S. " 176
Cryptosporidiosis in the acquired immunodeficiency syndrome: a case report 175
Local epidemics gone viral: Evolution and diffusion of the Italian HIV-1 recombinant form CRF60_BC 175
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 174
Reduced community viral load does not coincide with a reduction in the rate of new HIV diagnoses and recent infections: data from a region of southern Italy 173
A cyanobacterium-like body found in the stools of an HIV+ patient with diarrhoea 172
The elderly and direct antiviral agents: Constraint or challenge? 171
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: data from the Icona Foundation cohort. 170
Prevalence of urinary schistosomiasis in migrants in Apulia, a region of southern Italy, in the years 2006-2016 169
Safety and effectiveness of a 12-week course of sofosbuvir and simeprevir ± ribavirin in HCV-infected patients with or without HIV infection: a multicentre observational study 167
Survival in HIV-Infected Patients after a Cancer Diagnosis in the cART Era: Results of an Italian Multicenter Study. 165
Comment on: Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection 165
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 164
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 164
Chronic Inflammation in a Long-Term Cohort of HIV-Infected Patients According to the Normalization of the CD4:CD8 Ratio 163
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 163
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 162
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 161
Splenic abscesses as a first manifestation of Crohn's disease: A case report 160
Alterazioni oftalmoscopiche e fluorangiografiche in pazienti affetti da AIDS 159
Renal function changes in HCV-infected patients with chronic kidney disease during and after treatment with direct antiviral agents 159
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort 157
Detection of HHV-8 sequences in HIV-1 seropositive women 156
Cryoglobulinemia in subjects with HCV infection alone, HIV infection and HCV/HIV coinfection 156
Co-receptor switch during HAART is independent of virological success 156
Cohort Profile: Standardized Management of Antiretroviral Therapy Cohort (MASTER Cohort). 156
Incidence of tuberculosis among HIV-Infected patients receiving highly active antiretroviral therapy in Europe and North America 155
Access to Health Services for Undocumented Immigrants in Apulia 153
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 153
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 153
Improved virological outcome in non-B patients: a possible role for baseline coreceptor tropism 152
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA <50 cp/mL 149
Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies 148
Limiting severe outcomes and impact on intensive care units of moderate-intermediate 2009 pandemic influenza: role of infectious diseases units. 148
V3 sequences and paired HIV isolates from 52 non-subtype B HIV type 1-infected patients 147
CD4 and CD4/CD8 ratio progression in HIV-HCV infected patients after achievement of SVR 146
Gaining back what is lost: recovering the sense of smell in mild to moderate patients after COVID-19 146
Persistence of e antigen as prognostic marker in acute hepatitis B 145
Intrathecal immune response in human immunodeficiency virus infection 145
Premature lesions of the carotid vessels in HIV-1 infected patients treated with protease inhibitors 145
Effects of Therapy with Maraviroc on the Carotid Intima Media Thickness in HIV-1/HCV Co-infected Patients 145
Dalbavancin Efficacy and Impact on Hospital Length-of-Stay and Treatment Costs in Different Gram-Positive Bacterial Infections 144
A multidrug-resistant (MDR) HIV type 1 infection in a homosexual man and identified source patient 144
Evolution of antiretroviral prescription and response over a period of 8 years: An Italian multicentre observational prospective cohort study 144
Long-term efficacy and safety of switching from lamivudine + adefovir to tenofovir disoproxil fumarate in virologically suppressed patients 144
Management of MDR-TB in HIV co-infected patients in Eastern Europe: Results from the TB:HIV study 144
Early markers of tubular dysfunction in antiretroviral-experienced HIV-infected patients treated with tenofovir versus abacavir 143
Mutational patterns of paired blood and rectal biopsies in HIV-infected patients on HAART 143
L'anticorpo antinucleare (anti-HBc) e patologia acuta e cronica del fegato da virus B dell'epatite 142
Hepatic encephalopathy in the course of anti-HCV therapy with paritaprevir/ritonavir, ombitasvir, dasabuvir and ribavirin 142
Bone and kidney toxicity induced by nucleotide analogues in patients affected by HBV-related chronic hepatitis: a longitudinal study. 142
Are the proposed env mutations actually associated with resistance to maraviroc? 141
Epidemiological multicentric Italian society of infectious and tropical diseases study on prevalence of tropical diseases in hospitalized immigrants in Italy during 2002 140
Frequent cervicovaginal shedding of HIV-1 in asymptomatic, non-severely immunodeficient women 139
Cardiovascular risk factors in patients on long-term treatment with nevirapine- or efavirenz-based regimens 139
Risk of severe non AIDS events is increased among patients unable to increase their CD4 + T-cell counts >200+/μl despite effective HAART 138
Neutralizing antibodies to recombinant alpha-interferon and response to therapy in chronic hepatitis C virus infection 137
HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5years 137
An observational comparison of first-line combination antiretroviral treatment (cART) with 2NRTI and ATV/r or DRV/r in HIV-infected patients in Italy 137
HIV infection and protease genetic diversity in a rural area of the Southern Central African Republic 137
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 137
Pulmonary Artery Filling Defects in Covid-19 Patients Revealed Using CT Pulmonary Angiography: A Predictable Complication? 137
HIV-1 biological phenotype and predicted coreceptor usage based on V3 loop sequence in paired PBMC and plasma samples 136
Tocilizumab and corticosteroids for COVID-19 treatment in elderly patients 135
Parkinsonism in a patient with AIDS and cerebral opportunistic granulomatous lesions 135
Risk of AIDS in HIV seroconverters: a comparison between intravenous drug users and homosexual males 135
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice 135
Hepatitis B virus markers, alpha-fetoprotein and survival in fulminant viral hepatitis 134
Difficulties in classifying a/g recombinants: methodological problems or genetic variability? 134
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 134
HIV-1 variability and progression to AIDS: a longitudinal study 134
Immunological markers in HIV-infected pregnant and non-pregnant women 134
Reduced concentrations of HIV-RNA and TNF-alpha coexist in CSF of AIDS patients with progressive multifocal leukoencephalopathy 133
Analisi della cinetica replicativa in cultura primaria di isolati di HIV-1 da soggetti in vario stadio di malattia 133
Hepatitis B and immigrants: a SIMIT multicenter cross-sectional study 132
HCV and diabetes: Towards a 'sustained' glycaemic improvement after treatment with DAAs? 132
Adherence of hiv patients switching to emtricitabina+tenofovir disoproxil+rilpivirin. Real world evidence from italian administrative databases 131
Totale 16.821
Salva come PNG Salva come JPEG
Categoria #
all - tutte 207.186
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 207.186
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.044 0 0 0 0 137 183 103 196 183 170 452 620
2022/20234.439 797 317 185 448 630 517 39 504 775 34 101 92
2023/20241.501 143 343 83 75 95 394 39 39 28 41 30 191
2024/20256.263 89 117 688 215 110 543 333 556 278 323 934 2.077
2025/202614.073 1.850 726 1.097 1.551 1.311 747 1.541 400 1.240 1.211 449 1.950
2026/20274.813 494 802 1.284 2.206 27 0 0 0 0 0 0 0
Totale 51.314